Embecta Corp.

Embecta Corp. manufactures and distributes medical devices focused on diabetes care and management. The company's product portfolio includes pen needles, syringes, and safety injection devices designed for insulin delivery and blood glucose monitoring. Additionally, Embecta offers digital applications that help patients manage their diabetes through data tracking and health insights. The company sells primarily through wholesalers and distributors rather than direct-to-consumer channels.

The company operates across the United States and international markets, serving the diabetes management segment of the medical device industry. With approximately 1,850 full-time employees, Embecta maintains operations from its headquarters in Parsippany, New Jersey. The organization was originally established in 1924 and operates as a Delaware-incorporated entity trading on the Nasdaq exchange.